The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지
DOI QR코드

DOI QR Code

A Review of Randomized Controlled Trials of Traditional Chinese Medicine Treatment for Coronavirus Disease 2019 Patients

Coronavirus Disease-2019 환자 치료에 대한 중의 RCT 연구 동향

  • Park, Ju-heon (Dept. of Korean Medicine, Pusan National University of Korean Medicine) ;
  • Yoon, Seong-hoon (Dept. of Korean Medicine, Pusan National University of Korean Medicine) ;
  • Lee, In (Dept. of Korean Internal Medicine, Korean Medicine Hospital of Pusan National University)
  • 박주헌 (부산대학교 한의학전문대학원 한의학과) ;
  • 윤성훈 (부산대학교 한의학전문대학원 한의학과) ;
  • 이인 (부산대학교한방병원 한방내과)
  • Received : 2022.02.25
  • Accepted : 2022.03.28
  • Published : 2022.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: The purpose of this study is to investigate recent trends in randomized controlled trials (RCTs) on the treatment of Coronavirus disease 2019 (COVID-19) patients with traditional Chinese medicine (TCM) and analyze the results for the activation of COVID-19 Korean medicine research. Methods: We searched for RCTs published from December 2019 to October 2021 in the Chinese National Knowledge Infrastructure Database (CNKI). The investigation focused on the type of study, the purpose of the study, and the treatment methods. Results: A total of 8 RCTs were selected and analyzed from the 447 searched studies. All studies attempted to observe the effects of herbal medicine. Herbal medicine included granules, decoctions, and intravenous injections. The most frequently used herb type was drugs for clearing away heat and detoxification and releasing the exterior syndrome. In most studies, the effectiveness of TCM treatment of COVID-19 was significantly high. Conclusions: Although more quality studies are needed to support these results, TCM treatment for COVID-19 has been effective. Therefore, we hope that Korean medicine studies on infectious diseases will be actively conducted like TCM and contribute to national health.

Keywords

Acknowledgement

본 연구는 2021년도 부산대학교병원 임상연구비 지원으로 이루어졌음.

References

  1. 중앙방역대책본부.중앙사고수습본부. 코로나바이러스감염증-19 대응 지침(지자체용). 제10-1판. 질병관리청; 2021, p. 95-105.
  2. 중앙방역대책본부.중앙사고수습본부. 코로나19 국내예방접종완료자 관리 지침. 제3판. 질병관리청; 2021.
  3. 中华人民共和国国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案 第八版. 中华人民共和国国家卫生健康委员会; 2021.
  4. Yang M, Yang Sh, Yang M, You Dy. Systematic Review on the Treatment of Novel Coronavirus Pneumonia with Chinese Herbal Lianhua Qingwen. Chinese Journal of Drug Evaluation 2020;37(2):126-30.
  5. Zhang H, Wu J, Sun L, Wang T, Lu J. Meta analysis and trial sequential analysis of Lianhua Qingwen treating COVID-19. Prac J Med &Pharm 2020;37(12):1110-4.
  6. Zhang Lh, Zheng X, Bai X, Wang Q, Chen B, Wang H, et al. Association between use of Qingfei Paidu Tang and mortality in hospitalized patients with COVID-19: A national retrospective registry study. Phytomedicine 2021;85:153531. https://doi.org/10.1016/j.phymed.2021.153531
  7. Shuang Z, Jun F, Qin X, Tingrong H, Xiaoming X, Daixing Z, et al. Traditional Chinese medicine shenhuang granule in patients with severe/critical COVID-19: A randomized controlled multicenter trial. Phytomedicine 2021;89:153612. https://doi.org/10.1016/j.phymed.2021.153612
  8. XinYi Z, Lang L, YuLong Z, LiangDong X, Qin X, XiaoFan Z, et al. Efficacy and safety of Xiyanping injection in the treatment of COVID-19: A multicenter, prospective, open-label and randomized controlled trial. Phytotherapy research 2021;35(8):4401-10. https://doi.org/10.1002/ptr.7141
  9. Xiaolong X, Junhua Z, Wenke Z, Zifeng Y, Xuegong Z, Changfeng W, et al. Efficacy and safety of Reduning injection in the treatment of COVID-19: a randomized, multicenter clinical study. Annals of palliative medicine 2021;10(5):5146-55. https://doi.org/10.21037/apm-20-2121
  10. Hu F, Guo A, Huang L, Yu W, Liu G, Gao X, et al. Jinyinhua Liquid (金银花口服液) at Different Dosage Combined with Western Medicine Conventional Treatment for Common Type COVID-19: A Multicenter Trial of 187 Cases. Journal of Traditional Chinese Medicine 2021;62(6):510-5.
  11. Zhijian L, Wei C, Mingqing X, Hua W, Wei X, Cheng X, et al. The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: A prospective randomized controlled trial. European Journal of Integrative Medicine 2021;42(prepublish) 101305. https://doi.org/10.1016/j.eujim.2021.101305
  12. Jin W, Lu Y, Zhao W, Tang S, Sang X, Zhang L, et al. The Efficacy of Recommended Treatments with Integrated Chinese and Western Medicine on Coronavirus Disease 2019 (COVID-19) in Sichuan: A Clinical Trial Observation. Pharmacology and Clinics of Chinese Materia Medica 2020;36(6):6-10.
  13. Zhang Y, Lei L, Xu Y, Wei D, Hu F. Clinical Efficacy of Jinyinhua Oral Liquid in the Treatment of 80 Patients with Coronavirus Disease 2019. China Pharmaceuticals 2020;29(09):23-6.
  14. Sun H, Xu F, Zhang L, Wei C, Chen J, Wang Q, et al. Study on Clinical Efficacy of Lianhua Qingke Granule in Treatment of Mild and Ordinary COVID-19. Chinese Journal of Experimental Traditional Medical Formulae 2020;26(14):29-34.
  15. 식품의약품안전처 의약품정책과. 코로나19 치료제.백신 임상시험 등 진행현황. 질병관리본부; 2020.
  16. Pang W, Liu Z, Li N, Li Y, Yang F, Pang B et al. Chinese medical drugs for coronavirus disease 2019: A systematic review and meta-analysis. Integrative Medicine Research 2020;9(3):100477. https://doi.org/10.1016/j.imr.2020.100477
  17. Lee KE, Jeong SH, Jeong MJ, Choi YM, Song MD, Jang IS. Review on Herbal Medicine Treatment for Late Complications of COVID-19 Patients. J Int Korean Med 2021;42(1):53-66. https://doi.org/10.22246/jikm.2021.42.1.53
  18. Jeong SH, Lee KE, Jeong MJ, Song MD, Jang IS. A review on the treatment of Herbal Medicine for asymptomatically infected COVID-19 patients. J Korean Med 2021;42(1):99-109.
  19. Kang BH, Choi YK, Jeon CY, Yang SB. The Effects of Qingfei Paidu Decoction on Coronavirus Disease-19: A Narrative Review. J Int Korean Med 2021;41(3):424-33.
  20. Shi H, Guo W, Zhu H, Li M, Ung COL, Hu H, et al. Cost-Effectiveness Analysis of Xiyanping Injection (Andrographolide Sulfonate) for Treatment of Adult Community Acquired Pneumonia: A Retrospective, Propensity Score-Matched Cohort Study. Evidence-Based Complementary and Alternative Medicine 2019:4510591. https://doi.org/10.1155/2019/4510591
  21. Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature 2020;582:289-93. https://doi.org/10.1038/s41586-020-2223-y
  22. Enmozhi SK, Raja K, Sebastine I, Joseph J. Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach. Journal of Biomolecular Structure and Dynamics 2021;39(9):3092-8.
  23. Fuzimoto AD. An overview of the anti-SARS-CoV-2 properties of Artemisia annua, itsantiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment. Journal of Integrative Medicine 2021 (in press) https://doi.org/10.1016/j.joim.2021.07.003.
  24. Liu M, Yu Q, Yi Y, Xiao H, Putra DF, Ke K, et al. Antiviral activities of Lonicera japonica Thunb. Components against grouper iridovirus in vitro and in vivo. Aquaculture 2020;519:734882. https://doi.org/10.1016/j.aquaculture.2019.734882
  25. Guo S, Bao L, Li C, Sun J, Zhao R, Cui X. Antiviral activity of iridoid glycosides extracted from Fructus Gardeniae against influenza A virus by PACT-dependent suppression of viral RNA replication. Scientific Reports 2020;10(1):1897. https://doi.org/10.1038/s41598-020-58443-3
  26. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respitory Medicine 2020;8(4):420-2. https://doi.org/10.1016/S2213-2600(20)30076-X
  27. Qin C, Zhou L, Hu Z, Zhang S, Yang S, MD YT, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Infectious Disease Society of America 2020;71(15):762-8. https://doi.org/10.1093/cid/ciaa248
  28. Hu B, Huang S, Yin L. The cytokine storm and COVID-19. Journal of Medical Virology 2020;93(1):250-6. https://doi.org/10.1002/jmv.26232
  29. Tanaka T, Narazaki M, Kishimoto T. Immunotherapeutic implications of IL-6 blockade for cytokine storm. Immunotherapy 2016;8(8):959-70. https://doi.org/10.2217/imt-2016-0020
  30. 唐陆平, 李伟豪, 袁生. 金银花提取物改善脂多糖致大鼠急性肺损伤作用机制研究. Livestock and Poultry Industry 2019:10:1-3.
  31. Sun Y, Lyu W, Li H, Xiao Y, Yang M, Yang H, et al. Qingfei Paidu Decoction (清肺排毒汤) for Treatment of Mild/ Moderate COVID-19 in 295 Cases: A Multi-Centered. Journal of Traditional Chinese Medicine 2021;62(7):599-603.
  32. Zhang P, Pan GT. Clinical Study on the Improvement of Inflammatory Cytokines in Critically Ill Patients with COVID-19 Treated by Qingfei Paidu Decoction. Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology 2021;23(2):391-5.
  33. 이가현. 코로나19 치료제의 현황 및 유효성, 안전성. Journal of Korean Society of Health-System Pharmacists 2021;38(3):377-91.